Myasthenia gravis (MG) has been treatable for nearly 100 years. In 1934, the Scottish doctor Mary Broadfoot Walker, MD, discovered that the drug physostigmine improved muscle function in people with ...

Nicholas J. Silvestri, MD, recounts how the 2025 American Academy of Neurology meeting was an exciting and energizing event, particularly in the realm of myasthenia gravis (MG), where numerous new ...

Myasthenia gravis is an autoimmune disease in which antibodies bind to acetylcholine receptors or to functionally related molecules in the postsynaptic membrane at the neuromuscular junction. The ...

Five therapies are currently approved by the FDA for treating the symptoms of myasthenia gravis, allowing partial to complete remission. Research suggests that five new therapies may become available ...

Doctors may recommend oral medications such as pyridostigmine and various intravenous (IV) drugs for the treatment of myasthenia gravis. Thymectomy surgery and plasma exchange may also help. The aim ...

With treatment, myasthenia gravis can generally be controlled. In fact, about 50 percent of people who have their thymus gland removed may experience long-lasting, complete remission of myasthenia ...